| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ABR
|
active BCR-related
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGR2
|
anterior gradient 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHNAK
|
AHNAK nucleoprotein
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALKBH3
|
alkB, alkylation repair homolog 3 (E. coli)
|
|
ANLN
|
anillin, actin binding protein
|
|
ANXA1
|
annexin A1
|
|
ANXA13
|
annexin A13
|
|
ANXA6
|
annexin A6
|
|
ANXA7
|
annexin A7
|
|
APC
|
adenomatous polyposis coli
|
|
APH1A
|
APH1A gamma secretase subunit
|
|
AR
|
androgen receptor
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila)
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATAD2
|
ATPase family, AAA domain containing 2
|
|
ATF6
|
activating transcription factor 6
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
AURKA
|
aurora kinase A
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
BAX
|
BCL2-associated X protein
|
|
BBS2
|
Bardet-Biedl syndrome 2
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC6
|
baculoviral IAP repeat containing 6
|
|
BLMH
|
bleomycin hydrolase
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
|
BRS3
|
bombesin-like receptor 3
|
|
BSG
|
basigin (Ok blood group)
|
|
BTG2
|
BTG family, member 2
|
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
|
|
C1ORF52
|
chromosome 1 open reading frame 52
|
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBX2
|
chromobox homolog 2
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNA2
|
cyclin A2
|
|
CCNB2
|
cyclin B2
|
|
CCND1
|
cyclin D1
|
|
CCNE2
|
cyclin E2
|
|
CCNG1
|
cyclin G1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CD163
|
CD163 molecule
|
|
CD274
|
CD274 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CDC20
|
cell division cycle 20
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK19
|
cyclin-dependent kinase 19
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHD1
|
chromodomain helicase DNA binding protein 1
|
|
CHGA
|
chromogranin A
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIP2A
|
cellular inhibitor of PP2A
|
|
CLDN10
|
claudin 10
|
|
CLU
|
clusterin
|
|
COBLL1
|
cordon-bleu WH2 repeat protein-like 1
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COX2
|
|
|
CPNE1
|
copine I
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTAG1A
|
cancer/testis antigen 1A
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEK
|
DEK proto-oncogene
|
|
DHRS11
|
dehydrogenase/reductase (SDR family) member 11
|
|
DHX15
|
DEAH (Asp-Glu-Ala-His) box helicase 15
|
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5
|
|
DNAAF3
|
dynein, axonemal, assembly factor 3
|
|
DNAH5
|
dynein, axonemal, heavy chain 5
|
|
DNAI1
|
dynein, axonemal, intermediate chain 1
|
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1
|
|
DNER
|
delta/notch-like EGF repeat containing
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPT
|
dermatopontin
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DUSP26
|
dual specificity phosphatase 26 (putative)
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EGR1
|
early growth response 1
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELOVL7
|
ELOVL fatty acid elongase 7
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
EP300
|
E1A binding protein p300
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB6
|
EPH receptor B6
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERAL1
|
Era-like 12S mitochondrial rRNA chaperone 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRB
|
estrogen-related receptor beta
|
|
ETFA
|
electron-transfer-flavoprotein, alpha polypeptide
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FAM110B
|
family with sequence similarity 110, member B
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHL2
|
four and a half LIM domains 2
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLNA
|
filamin A, alpha
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GAK
|
cyclin G associated kinase
|
|
GATA2
|
GATA binding protein 2
|
|
GATAD2B
|
GATA zinc finger domain containing 2B
|
|
GDF15
|
growth differentiation factor 15
|
|
GGNBP2
|
gametogenetin binding protein 2
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GLI2
|
GLI family zinc finger 2
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR158
|
G protein-coupled receptor 158
|
|
GPR17
|
G protein-coupled receptor 17
|
|
GPR42
|
G protein-coupled receptor 42 (gene/pseudogene)
|
|
GPX2
|
glutathione peroxidase 2
|
|
GRB10
|
growth factor receptor-bound protein 10
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GRN
|
granulin
|
|
GRP
|
gastrin-releasing peptide
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSR
|
glutathione reductase
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HADHA
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit
|
|
HADHB
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC6
|
histone deacetylase 6
|
|
HECTD2
|
HECT domain containing E3 ubiquitin protein ligase 2
|
|
HEPACAM
|
hepatic and glial cell adhesion molecule
|
|
HES6
|
hes family bHLH transcription factor 6
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST1H4A
|
histone cluster 1, H4a
|
|
HIST1H4B
|
histone cluster 1, H4b
|
|
HIST1H4C
|
histone cluster 1, H4c
|
|
HIST1H4D
|
histone cluster 1, H4d
|
|
HIST1H4E
|
histone cluster 1, H4e
|
|
HIST1H4F
|
histone cluster 1, H4f
|
|
HIST1H4H
|
histone cluster 1, H4h
|
|
HIST1H4I
|
histone cluster 1, H4i
|
|
HIST1H4J
|
histone cluster 1, H4j
|
|
HIST1H4K
|
histone cluster 1, H4k
|
|
HIST1H4L
|
histone cluster 1, H4l
|
|
HIST2H4A
|
histone cluster 2, H4a
|
|
HIST2H4B
|
histone cluster 2, H4b
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HNRNPDL
|
heterogeneous nuclear ribonucleoprotein D-like
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA10
|
homeobox A10
|
|
HOXB13
|
homeobox B13
|
|
HP
|
haptoglobin
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B13
|
hydroxysteroid (17-beta) dehydrogenase 13
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPB3
|
heat shock 27kDa protein 3
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IL2
|
interleukin 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
ING3
|
inhibitor of growth family, member 3
|
|
INSR
|
insulin receptor
|
|
INTS6
|
integrator complex subunit 6
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM3B
|
lysine (K)-specific demethylase 3B
|
|
KDM4B
|
lysine (K)-specific demethylase 4B
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIDINS220
|
kinase D-interacting substrate, 220kDa
|
|
KIF4A
|
kinesin family member 4A
|
|
KLF14
|
Kruppel-like factor 14
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLRC4-KLRK1
|
KLRC4-KLRK1 readthrough
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRT18
|
keratin 18, type I
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LAT2
|
linker for activation of T cells family, member 2
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LCN2
|
lipocalin 2
|
|
LDHA
|
lactate dehydrogenase A
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS4
|
lectin, galactoside-binding, soluble, 4
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LMTK2
|
lemur tyrosine kinase 2
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1
|
|
LRRC4
|
leucine rich repeat containing 4
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MED1
|
mediator complex subunit 1
|
|
MED15
|
mediator complex subunit 15
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEIS2
|
Meis homeobox 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MID1
|
midline 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSMB
|
microseminoprotein, beta-
|
|
MST1
|
macrophage stimulating 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYSM1
|
Myb-like, SWIRM and MPN domains 1
|
|
N6AMT1
|
N-6 adenine-specific DNA methyltransferase 1 (putative)
|
|
NCAPG
|
non-SMC condensin I complex, subunit G
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NDRG2
|
NDRG family member 2
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOTCH1
|
notch 1
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPEPPS
|
aminopeptidase puromycin sensitive
|
|
NPRL2
|
nitrogen permease regulator-like 2 (S. cerevisiae)
|
|
NPY
|
neuropeptide Y
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NR6A1
|
nuclear receptor subfamily 6, group A, member 1
|
|
NRF1
|
nuclear respiratory factor 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTS
|
neurotensin
|
|
NUF2
|
NUF2, NDC80 kinetochore complex component
|
|
NUP62
|
nucleoporin 62kDa
|
|
OPN1LW
|
opsin 1 (cone pigments), long-wave-sensitive
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAGE4
|
P antigen family, member 4 (prostate associated)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP2
|
poly (ADP-ribose) polymerase 2
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PCBD1
|
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha
|
|
PCBP4
|
poly(rC) binding protein 4
|
|
PCDH7
|
protocadherin 7
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDIK1L
|
PDLIM1 interacting kinase 1 like
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PHF8
|
PHD finger protein 8
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIR
|
pirin (iron-binding nuclear protein)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLCL1
|
phospholipase C-like 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLK1
|
polo-like kinase 1
|
|
PLRG1
|
pleiotropic regulator 1
|
|
PLXNB1
|
plexin B1
|
|
PNP
|
purine nucleoside phosphorylase
|
|
POLD3
|
polymerase (DNA-directed), delta 3, accessory subunit
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP3CC
|
protein phosphatase 3, catalytic subunit, gamma isozyme
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PROL1
|
proline rich, lacrimal 1
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PRRX2
|
paired related homeobox 2
|
|
PRX
|
periaxin
|
|
PSAP
|
prosaposin
|
|
PSAT1
|
phosphoserine aminotransferase 1
|
|
PSCA
|
prostate stem cell antigen
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTOV1
|
prostate tumor overexpressed 1
|
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1
|
|
PTPA
|
protein phosphatase 2 phosphatase activator
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYCR1
|
pyrroline-5-carboxylate reductase 1
|
|
RAB1A
|
RAB1A, member RAS oncogene family
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RB1
|
retinoblastoma 1
|
|
RBM39
|
RNA binding motif protein 39
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHO
|
rhodopsin
|
|
RIOX1
|
ribosomal oxygenase 1
|
|
RMC1
|
regulator of MON1-CCZ1
|
|
RNF41
|
ring finger protein 41, E3 ubiquitin protein ligase
|
|
RNF7
|
ring finger protein 7
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RUNX2
|
runt-related transcription factor 2
|
|
SCIN
|
scinderin
|
|
SDC1
|
syndecan 1
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SESN2
|
sestrin 2
|
|
SESN3
|
sestrin 3
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC2A4RG
|
SLC2A4 regulator
|
|
SLC35A2
|
solute carrier family 35 (UDP-galactose transporter), member A2
|
|
SLC47A1
|
solute carrier family 47 (multidrug and toxin extrusion), member 1
|
|
SLC5A6
|
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMARCE1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP6
|
Sp6 transcription factor
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
|
|
SPOP
|
speckle-type POZ protein
|
|
SPRTN
|
SprT-like N-terminal domain
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRD5A3
|
steroid 5 alpha-reductase 3
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRRM4
|
serine/arginine repetitive matrix 4
|
|
SST
|
somatostatin
|
|
SSTR4
|
somatostatin receptor 4
|
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
|
ST3GAL2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STC2
|
stanniocalcin 2
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STEAP2
|
STEAP family member 2, metalloreductase
|
|
STK11
|
serine/threonine kinase 11
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SYP
|
synaptophysin
|
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
TARP
|
TCR gamma alternate reading frame protein
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TIMM8A
|
translocase of inner mitochondrial membrane 8 homolog A (yeast)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TMED10
|
transmembrane emp24-like trafficking protein 10 (yeast)
|
|
TMPO
|
thymopoietin
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TP53
|
tumor protein p53
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRAM1
|
translocation associated membrane protein 1
|
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TST
|
thiosulfate sulfurtransferase (rhodanese)
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TXNDC5
|
thioredoxin domain containing 5 (endoplasmic reticulum)
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBIAD1
|
UbiA prenyltransferase domain containing 1
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
ULBP1
|
UL16 binding protein 1
|
|
ULBP2
|
UL16 binding protein 2
|
|
ULBP3
|
UL16 binding protein 3
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
USP12
|
ubiquitin specific peptidase 12
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
WASF1
|
WAS protein family, member 1
|
|
WDR5
|
WD repeat domain 5
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
|
WT1
|
Wilms tumor 1
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YIPF6
|
Yip1 domain family, member 6
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZBED1
|
zinc finger, BED-type containing 1
|
|
ZBTB46
|
zinc finger and BTB domain containing 46
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZFX
|
zinc finger protein, X-linked
|
|
ZNF645
|
zinc finger protein 645
|
